Cargando…
Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment
Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancers and is the third leading cause of cancer-related mortality worldwide. Multifactorial drug resistance is regarded as the major cause of treatment failure in HCC. Accumulating evidence shows that the constituents of the...
Autores principales: | Zhang, Jiaxin, Han, Huiqiong, Wang, Lei, Wang, Wenjia, Yang, Mei, Qin, Yanru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705776/ https://www.ncbi.nlm.nih.gov/pubmed/36457492 http://dx.doi.org/10.3389/fonc.2022.988956 |
Ejemplares similares
-
Targeting the Microenvironment in Esophageal Cancer
por: Wang, Lei, et al.
Publicado: (2021) -
Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities
por: Kalyanaraman, Balaraman, et al.
Publicado: (2022) -
Editorial: The role of tumor microenvironment in primary liver cancer therapeutic resistance
por: Pu, Zhangya, et al.
Publicado: (2022) -
Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment
por: Cao, Jennifer, et al.
Publicado: (2023) -
Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial–Mesenchymal transition
por: Duan, Xirui, et al.
Publicado: (2022)